It probably is. it doesn’t recommend KM back. There could be a second part that says:
However under your stewardship the company was unsuccessful in several attempts to commercialise the product, you oversold to the market where you were in the products lifecycle and had let shareholders downtime and time again.
- Forums
- ASX - By Stock
- Ann: Combined Letter to Shareholders
It probably is. it doesn’t recommend KM back. There could be a...
Featured News
Add 14D (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.0¢ |
Change
0.002(2.56%) |
Mkt cap ! $19.05M |
Open | High | Low | Value | Volume |
8.0¢ | 8.0¢ | 8.0¢ | $860 | 10.75K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 48764 | 7.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.0¢ | 82000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 48764 | 0.079 |
1 | 93000 | 0.078 |
3 | 230015 | 0.077 |
1 | 19977 | 0.076 |
1 | 13333 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.090 | 82000 | 2 |
0.095 | 76503 | 2 |
0.098 | 1899 | 1 |
0.100 | 200000 | 1 |
0.105 | 20000 | 1 |
Last trade - 10.16am 06/05/2024 (20 minute delay) ? |
Featured News
14D (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online